nsion (HR 1.80, 95% CI 1.13 to 2.86), those with CVD (HR 1.66, 95% CI 1.17 to 2.36), those receiving diabetes treatment (HR 1.70, 95% CI 1.18 to 2.44), and those with higher glycated hemoglobin A1c (glycated hemoglobin A1c ≥ 6.5%, HR 1.56, 95% CI 1.12 to 2.18), although the P values for interaction did not reach statistical significance (All P for interaction > 0.05) The association between the usage of table salt and all-cause mortality was generally consistent across subgroups (P for interaction > 0.05), with a few exceptions (Table S2 ).
← all excerpts
Usage of table salt and risk of all-cause and cardiovascular disease mortality among patients with diabetes: a national population-based cohort study.
1
—
—